Qinghui Liannuo
Beijing · Founded 2018
About Qinghui Liannuo
Qinghui Liannuo is a scientific and technological innovation enterprise that transforms Tsinghua University's achievements in the research and development and application of immunotherapy technology. Actively promote the development of the ╬│╬┤-T cell immunotherapy industry. Committed to bringing good news to patients with refractory and recurrent solid tumors and hematomas.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2025)
- Website: http://www.unicetbio.com
- Phone: +86 13070108016
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/qinghui-liannuo-112490 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.